VP Finance

Boston, Massachusetts

Seaport Therapeutics
Apply for this Job

VP, Finance (Controller)

Seaport Therapeutics is seeking a VP, Finance (Controller) to join their team. This role would be the first hire in the Finance organization and will help design and implement the Seaport financials controls.

Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs. The Company has a proven strategy of advancing clinically validated mechanisms previously held back by limitations that are overcome with its proprietary Glyph TM technology platform. All the therapeutic candidates in its pipeline of first and best-in-class medicines are based on the Glyph platform, which is uniquely designed to enable oral bioavailability, bypass first-pass metabolism and reduce hepatotoxicity and other side effects. Seaport is led by an experienced team that was involved in inventing and advancing KarXT and other neuropsychiatric medicines and are guided by an extensive network of renowned scientists, clinicians and key opinion leaders across neurological specialties. For more information, please visit .

Responsibilities:

  • Monthly close processes and procedures, general accounting, internal management reporting and technical accounting matters.
  • Supervise AR, AP, payroll, technical accounting, fixed assets, treasury, and equity awards.
  • Prepare the consolidated financial statements; ensure proper external reporting and filing in compliance with regulations.
  • Partner with the management team by researching, evaluating, and documenting accounting implications of complex transactions and collaborations; manage technical accounting assessments.
  • Serve as the liaison to external auditors and manage the annual financial audit.
  • Recommend and implement process improvements to enhance efficiency, internal controls and enable timely business decisions.
  • Partner and collaborate with business stakeholders to recommend system improvements or integrations to enable improved financial reporting or analyses.
  • Ensure processes and people are in place to deliver timely and accurate monthly financial statements.
  • Support the establishment and monitoring of strong internal controls across the organization.
  • Coordinate with the insurance broker and carriers to properly mitigate risk.
  • Build financial infrastructure and policies that will support the company's growth and drive continuous improvements in financial systems and processes.
  • Serve as a business partner and build relationships cross-functionally to foster collaboration both inside and outside of accounting.
  • Direct and lead accounting teams in the development, implementation, and oversight of company-wide accounting policies and controls consistent with SEC, US GAAP, and Sarbanes-Oxley compliance.
  • Manage relationship and reporting matters with the audit firm and interface effectively with external and internal audit resources to resolve complex accounting and auditing issues.
  • Responsible for departmental operating budgets and preparation of board-level and management reports.
  • Support analysis of key business development initiatives and partnerships from an accounting perspective.
  • Be a key team member in identifying and managing areas of enterprise risk.
  • Engage with Audit Committee of the Board of Directors and executive management through compelling presentations.
  • Other projects based on business needs.

Requirements:

  • Bachelors' degree in Accounting with current CPA accreditation required; Masters' degree or MBA is preferred
  • 8+ years of work experience in public accounting
  • 5+ years of biotech/pharmaceutical industry experience
  • Proficiency with Oracle Fusion, NetSuite, Carta, Prendio, and Bill is beneficial
  • Experience with the implementation of an ERP system such as NetSuite or Oracle
  • Experience with the implementation of a T&E spend management system such as Concur
  • Experience preparing a company for an IPO is highly preferred
Date Posted: 14 June 2024
Apply for this Job